With a positive alpha of 3.34, managers in this portfolio are skilled in picking securities that generate better-than-benchmark returns.Īs competition heats up in the mutual fund market, costs become increasingly important. Another factor to consider is alpha, as it reflects a portfolio's performance on a risk-adjusted basis relative to a benchmark-in this case, the S&P 500. Investors should note that the fund has a 5-year beta of 1.04, so it is likely going to be more volatile than the market at large. These results could imply that the fund is a better choice than its peers during a sliding market environment. In FSRPX's case, the fund lost 40.11% in the most recent bear market and outperformed its peer group by 10%. One cannot ignore the volatility of this segment, however, as it is always important for investors to remember the downside to any potential investment. This makes the fund less volatile than its peers over the past half-decade. Over the past 5 years, the standard deviation of the fund is 14.25% compared to the category average of 14.59%. Compared to the category average of 14.16%, the standard deviation of FSRPX over the past three years is 15.5%. The lower the standard deviation, the less volatility the fund experiences. When looking at a fund's performance, it is also important to note the standard deviation of the returns. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 18.48%, which places it in the top third during this time-frame. This fund in particular has delivered a 5-year annualized total return of 15.52%, and is in the top third among its category peers. Of course, investors look for strong performance in funds.

Parasite in the city 1.04